Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

HIV type-1 latency: targeted induction of proviral reservoirs.

Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z.

Antivir Chem Chemother. 2009;19(5):177-87. Review.

PMID:
19483266
[PubMed - indexed for MEDLINE]
2.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.

Redel L, Le Douce V, Cherrier T, Marban C, Janossy A, Aunis D, Van Lint C, Rohr O, Schwartz C.

J Leukoc Biol. 2010 Apr;87(4):575-88. doi: 10.1189/jlb.0409264. Epub 2009 Oct 2. Review.

PMID:
19801499
[PubMed - indexed for MEDLINE]
Free Article
3.

Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs.

Sánchez-Duffhues G, Vo MQ, Pérez M, Calzado MA, Moreno S, Appendino G, Muñoz E.

Curr Drug Targets. 2011 Mar 1;12(3):348-56. Review.

PMID:
20955147
[PubMed - indexed for MEDLINE]
4.

Latency: the hidden HIV-1 challenge.

Marcello A.

Retrovirology. 2006 Jan 16;3:7. Review.

PMID:
16412247
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.

Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D.

J Virol. 2002 Sep;76(18):9481-92.

PMID:
12186930
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Molecular biological assessment methods and understanding the course of the HIV infection.

Katzenstein TL.

APMIS Suppl. 2003;(114):1-37. Review.

PMID:
14626050
[PubMed - indexed for MEDLINE]
7.

Reservoirs of HIV replication after successful combined antiretroviral treatment.

Belmonte L, Baré P, de Bracco MM, Ruibal-Ares BH.

Curr Med Chem. 2003 Feb;10(4):303-12. Review.

PMID:
12570703
[PubMed - indexed for MEDLINE]
8.

HIV reservoirs, latency, and reactivation: prospects for eradication.

Dahl V, Josefsson L, Palmer S.

Antiviral Res. 2010 Jan;85(1):286-94. doi: 10.1016/j.antiviral.2009.09.016. Epub 2009 Oct 4. Review.

PMID:
19808057
[PubMed - indexed for MEDLINE]
9.

Molecular mechanisms of HIV-1 proviral latency.

Bisgrove D, Lewinski M, Bushman F, Verdin E.

Expert Rev Anti Infect Ther. 2005 Oct;3(5):805-14. Review.

PMID:
16207172
[PubMed - indexed for MEDLINE]
10.

Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation.

Avila L, Perez M, Sanchez-Duffhues G, Hernández-Galán R, Muñoz E, Cabezas F, Quiñones W, Torres F, Echeverri F.

Phytochemistry. 2010 Feb;71(2-3):243-8. doi: 10.1016/j.phytochem.2009.10.005. Epub 2009 Nov 10.

PMID:
19897215
[PubMed - indexed for MEDLINE]
11.

From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.

Shan L, Siliciano RF.

Bioessays. 2013 Jun;35(6):544-52. doi: 10.1002/bies.201200170. Epub 2013 Apr 24. Review.

PMID:
23613347
[PubMed - indexed for MEDLINE]
12.

Regulation of human immunodeficiency virus-1 latency and its reactivation.

Verdin E.

Bull Mem Acad R Med Belg. 2008;163(6):355-64; discussion 364-5.

PMID:
19445107
[PubMed - indexed for MEDLINE]
13.

A unified concept of HIV latency.

Bagasra O.

Expert Opin Biol Ther. 2006 Nov;6(11):1135-49. Review.

PMID:
17049012
[PubMed - indexed for MEDLINE]
14.

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR, Pomerantz RJ.

Blood. 2001 Nov 15;98(10):3006-15.

PMID:
11698284
[PubMed - indexed for MEDLINE]
Free Article
16.

Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.

Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E.

Curr HIV Res. 2010 Sep;8(6):418-29.

PMID:
20636281
[PubMed - indexed for MEDLINE]
17.

Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

Sedaghat AR, Siliciano RF, Wilke CO.

BMC Infect Dis. 2008 Jan 2;8:2. doi: 10.1186/1471-2334-8-2.

PMID:
18171475
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.

Siliciano RF.

Top HIV Med. 2005 Aug-Sep;13(3):96-100.

PMID:
16170226
[PubMed - indexed for MEDLINE]
Free Article
19.

HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.

Kulkosky J, Bray S.

Curr HIV Res. 2006 Apr;4(2):199-208. Review.

PMID:
16611058
[PubMed - indexed for MEDLINE]
20.

[Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].

Llibre JM, Martínez-Picado J.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:17-22. Review. Spanish.

PMID:
19572421
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk